KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 75 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,401,000 | 0.0% | 153,449 | 0.0% | 0.62% | +3.7% |
| Q4 2018 | $1,401,000 | -19.7% | 153,449 | +50.4% | 0.60% | +0.2% |
| Q3 2018 | $1,744,000 | +2135.9% | 102,006 | +774.7% | 0.60% | +1516.2% |
| Q2 2016 | $78,000 | -25.0% | 11,662 | 0.0% | 0.04% | -26.0% |
| Q1 2016 | $104,000 | -32.9% | 11,662 | 0.0% | 0.05% | -32.4% |
| Q4 2015 | $155,000 | +26.0% | 11,662 | 0.0% | 0.07% | +19.4% |
| Q3 2015 | $123,000 | -61.2% | 11,662 | 0.0% | 0.06% | -56.9% |
| Q2 2015 | $317,000 | -11.2% | 11,662 | 0.0% | 0.14% | -11.7% |
| Q1 2015 | $357,000 | +149.7% | 11,662 | +205.4% | 0.16% | +143.3% |
| Q4 2014 | $143,000 | +7.5% | 3,819 | 0.0% | 0.07% | – |
| Q3 2014 | $133,000 | -25.3% | 3,819 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $178,000 | – | 3,819 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |